These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Altered insulin-like growth factor-2 signaling is associated with psychopathology and cognitive deficits in patients with schizophrenia. Yang YJ; Luo T; Zhao Y; Jiang SZ; Xiong JW; Zhan JQ; Yu B; Yan K; Wei B PLoS One; 2020; 15(3):e0226688. PubMed ID: 32191705 [TBL] [Abstract][Full Text] [Related]
6. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T; Busby W; Clemmons DR Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319 [TBL] [Abstract][Full Text] [Related]
7. The maternal insulin-like growth factor (IGF) and IGF-binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies. Miell JP; Langford KS; Jones JS; Noble P; Westwood M; White A; Nicolaides KH J Clin Endocrinol Metab; 1997 Jan; 82(1):287-92. PubMed ID: 8989275 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075 [TBL] [Abstract][Full Text] [Related]
9. Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects. Akanji AO; Ohaeri JU; Al-Shammri SA; Fatania HR Clin Chem Lab Med; 2007; 45(9):1229-31. PubMed ID: 17635080 [TBL] [Abstract][Full Text] [Related]
10. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Kricker JA; Towne CL; Firth SM; Herington AC; Upton Z Endocrinology; 2003 Jul; 144(7):2807-15. PubMed ID: 12810534 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation. Weber MM; Auernhammer CJ; Lee PD; Engelhardt D; Zachoval R Horm Res; 2002; 57(3-4):105-12. PubMed ID: 12006706 [TBL] [Abstract][Full Text] [Related]
14. Binding properties of insulin-like growth factor binding protein-3 (IGFBP-3), IGFBP-3 N- and C-terminal fragments, and structurally related proteins mac25 and connective tissue growth factor measured using a biosensor. Vorwerk P; Hohmann B; Oh Y; Rosenfeld RG; Shymko RM Endocrinology; 2002 May; 143(5):1677-85. PubMed ID: 11956149 [TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide on the expression of insulin-like growth factors and the insulin-like growth factor binding proteins throughout the lifespan of the human corpus luteum. Iñiguez G; Villavicencio A; Gabler F; Palomino A; Vega M Reproduction; 2001 Dec; 122(6):865-73. PubMed ID: 11905402 [TBL] [Abstract][Full Text] [Related]
16. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system. De Boer L; Van Duyvenvoorde HA; Willemstein-Van Hove EC; Hoogerbrugge CM; Van Doorn J; Maassen JA; Karperien M; Wit JM Eur J Endocrinol; 2004 Sep; 151(3):333-41. PubMed ID: 15362962 [TBL] [Abstract][Full Text] [Related]
18. IGF-I, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls. Rooman RP; De Beeck LO; Martin M; Van Doorn J; Mohan S; Du Caju MV Eur J Endocrinol; 2002 Jun; 146(6):823-9. PubMed ID: 12039703 [TBL] [Abstract][Full Text] [Related]
19. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
20. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Frystyk J; Skjaerbaek C; Vestbo E; Fisker S; Orskov H Diabetes Metab Res Rev; 1999; 15(5):314-22. PubMed ID: 10585616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]